Despite more challenging growth conditions, Chr. Hansen delivers a strong EBIT margin and a healthy cash flow, while also making significant progress on key strategic priorities. CEO Mauricio Graber says: “2018/19 was a solid year for Chr. Hansen, although it was not without its challenges as tougher market conditions especially in emerging markets made it more difficult to grow to the level of our ambition. We ended the year with 7 % organic growth for the group, at the low end of the guidance provided in June. However, we are satisfied that we delivered well on the financial targets for EBIT margin and free cash flow that we set at the beginning of the year, with EBIT margin before special items reaching 29.6 % and 17 % growth in free cash flow before acquisitions and special items.”

For the full year, Food Cultures & Enzymes delivered solid organic growth of 8 %, while Health & Nutrition delivered 9 % and Natural Colours delivered 3 %. In Q4, organic growth came down as expected for all three business areas, as the company continued to see macroeconomic challenges in emerging markets, primarily impacting Food Cultures & Enzymes and Natural Colours.